Vaccini, optimistic von der Leyen: "70 per cent of the EU will be immunized by the summer"

The current situation is difficult but for Ursula von der Leyen, president of the EU commission, the goal of immunizing 70 percent of the European population soon by the summer is possible and achievable. “We are still in a very worrying situation between variants and third wave. I can understand how difficult and frustrating the situation is, how much our citizens suffer but I say that we will judge the crisis when we have overcome it. I am deeply convinced that we will all understand that the right approach was to be together as a European Union. "The president said in an interview with Repubblica." When we negotiated contracts with companies that had requests from all over the world, we were 450 million Europeans. No single country would have obtained such a vast portfolio of vaccines and today we see how important it is to have a wide choice because you can always have problems with one manufacturer. I can't even imagine what would have happened if 4 or 5 Member States had they had the vaccines and the others had not: it would have been devastating for European unity and would have destroyed the single market. It is true that we are going through very critical situations, but we all realize that the best approach to get out of them is to work together at the European level " . "In Europe we have immunized 7 million people with AstraZeneca with very good results and we are starting to see that the mortality rate of the elderly over 80 is going down despite the spread of infections. We are starting to see the effect of the vaccine and it is It was very important that EMA took the time to thoroughly analyze all the data to come to the conclusion that it is safe and effective. And on exporting doses to the UK, von der Leyen points out: "In the contract with AstraZeneca it is expected the company to deliver to the Union from both European and British plants, but so far we have not received any supplies from them as AstraZeneca's European production has left the EU for the UK. "" We sent today (yesterday for those who read, ed) a letter of formal notice to AstraZeneca because we want to activate a structured dispute resolution process. There are several open points about contracts and the best way to clarify them is this, he replies. Will Europe sign a joint contract with Sputnik? "A good vaccine has no nationality, but it must prove effective and safe to pass the EMA exam. I remember that Sputnik is now under rolling review, but has not yet requested formal authorization. The second fundamental point - and we see it with AstraZeneca - is that a company must be able to meet supplies and at the moment we have not seen any evidence of Sputnik's production capacity. Before authorizing, EMA must also certify the production sites and their quality ".  

AstraZeneca, the EMA verdict: "Effective vaccine, benefits outweigh the risks"
Von der Leyen: "From AstraZeneca less than 10% of the agreed doses"
Vaccines.
British authority: no evidence against AstraZeneca
Von der Leyen: "On export vaccines we want reciprocity. I trust AstraZeneca, Ema will clarify"

Share

March 19, 2021 The current situation is difficult but for Ursula von der Leyen, president of the EU commission, the goal of immunizing 70 percent of the European population by the summer is possible and achievable.

“We are still in a very worrying situation between variants and third wave.

I can understand how difficult and frustrating the situation is, how much our citizens suffer but I say that we will judge the crisis when we have overcome it.

I am deeply convinced that we will all understand that the right approach was to be together as a European Union. "The president said in an interview with Repubblica." When we negotiated contracts with companies that had requests from all over the world, we were 450 million Europeans. No single country would have obtained such a vast portfolio of vaccines and today we see how important it is to have a wide choice because you can always have problems with one manufacturer. I can't even imagine what would have happened if 4 or 5 Member States had they had the vaccines and the others had not: it would have been devastating for European unity and would have destroyed the single market. It is true that we are going through very critical situations, but we all realize that the best approach to get out of them is to work together at the European level " .

"In Europe we have immunized 7 million people with AstraZeneca with very good results and we are starting to see that the mortality rate of the elderly over 80 is going down despite the spread of infections. We are starting to see the effect of the vaccine and it is It was very important that EMA took the time to thoroughly analyze all the data to come to the conclusion that it is safe and effective. And on exporting doses to the UK, von der Leyen points out: "In the contract with AstraZeneca it is expected the company to deliver to the Union from both European and British plants, but so far we have not received any supplies from them as AstraZeneca's European production has left the EU for the UK. "" We sent today (yesterday for those who read, ed) a letter of formal notice to AstraZeneca because we want to activate a structured dispute resolution process.

There are several open points about contracts and the best way to clarify them is this, reply.

Will Europe sign a joint contract with Sputnik?

"A good vaccine has no nationality, but it must prove effective and safe to pass the EMA exam. I remember that Sputnik is now under rolling review, but has not yet requested formal authorization. The second fundamental point - and we see it with AstraZeneca - is that a company must be able to comply with supplies and at the moment we have not seen any evidence of Sputnik's production capacity. Before authorizing, EMA must also certify the production sites and their quality ".

Vaccini, optimistic von der Leyen: "70 per cent of the EU will be immunized by the summer"

You may like

Trends 24h

Latest